Prescription Drug Prices Fall 3.1% in Latest Year—Steepest Decline Since 1963
Prescription drug prices recorded their sharpest annual decline in over 60 years, falling 3.1% in the year ending July 2026. Generics and discount weight-loss drugs drove much of the drop, offering relief for people paying out-of-pocket for medications.
In what experts are calling a historic reversal, prescription drug prices fell 3.1 percent in the year ending July 2026—the steepest annual decline since the government began tracking the data in 1963. The collapse in drug costs comes from a combination of factors: increased generic drug competition, the proliferation of discount GLP-1 weight-loss medications, and ongoing federal efforts to negotiate drug prices for Medicare beneficiaries.
The Medicare drug price negotiation program—authorized under the Inflation Reduction Act—has begun its work. CMS negotiated lower prices for 10 high-cost drugs treating conditions like heart disease, diabetes, and cancer, with savings estimated at $1.5 billion for people with Medicare Part D coverage. Negotiations for additional drugs scheduled through 2027 are proceeding.
While list prices on some medications continue to rise (drugmakers plan increases on at least 350 brand-name drugs in 2026), actual out-of-pocket costs have declined thanks to generic alternatives and direct-to-consumer discount programs.
If you or your family depend on prescription medications, this trend may mean immediate savings. If you're on Medicare Part D, ask your pharmacy about the 10 negotiated drugs. If you're buying private insurance, shop around during open enrollment—prices vary significantly by plan and pharmacy benefit managers are forced to pass savings to enrollees.
Sources
MyHAbroad is an independent app and is not affiliated with, endorsed by, or representing any government or public authority. This is general information only — not legal, tax, medical, or financial advice. Always verify with the official source before acting:
